Literature DB >> 32341455

Intronic variant in IQGAP3 associated with hereditary neuropathy with proximal lower dominancy, urinary disturbance, and paroxysmal dry cough.

Shiroh Miura1,2,3, Kengo Kosaka2, Tomofumi Shimojo2, Eiji Matsuura4, Kazuhito Noda5, Ryuta Fujioka6, Shin-Ichiro Mori3,7, Fujio Umehara8, Toru Iwaki7, Ken Yamamoto9, Hirotomo Saitsu10, Hiroki Shibata11.   

Abstract

In 2008, we reported a clinically and genetically new type of autosomal dominant disorder of motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough. To identify the nucleotide variant causative of this disease, we reanalyzed the linkage of the original Japanese pedigree including seven newly ascertained subjects with updated information. We assigned the locus of the disease to 1p13.3-q23 (maximum logarithm-of-odds score = 2.71). Exome sequencing for five patients and one healthy relative from the pedigree revealed 2526 patient-specific single-nucleotide variants (SNVs). By rigorous filtering processes using public databases, our linkage results, and functional prediction, followed by Sanger sequencing of the pedigree and 520 healthy Japanese individuals, we identified an intronic SNV in IQGAP3, a gene known to be associated with neurite outgrowth. Upon pathological examination of the sural nerve, moderate, chronic, mainly axonal neuropathy was observed. By histochemical analyses, we observed a patient-specific increase of IQGAP3 expression in the sural nerve. We concluded that the variant of IQGAP3 is associated with the disease in our pedigree.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32341455     DOI: 10.1038/s10038-020-0761-7

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  1 in total

1.  Overexpression and biological function of IQGAP3 in human pancreatic cancer.

Authors:  Weihong Xu; Bin Xu; Yiting Yao; Xiaoling Yu; Hua Cao; Jun Zhang; Jie Liu; Huiming Sheng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.